Scientific Program
| 8:15 AM | Introduction |
| 8:30 AM | IL-15R alpha transpresentation of IL-15: implications for cancer therapy Dr. Tom Waldmann (NCI-Bethesda) |
| 9:10 AM | Possible roles for IL-15 in the cell transfer therapy of cancer Dr. Steven Rosenberg (NCI-Bethesda) (NCI-Frederick) |
| 9:50 AM |
Molecular Biology and Regulation of IL-15 and IL-15Ra Expression Dr. George Pavlakis (NCI-Frederick) |
| 10:30 AM | Coffee Break |
| 10:50 AM | Visualizing IL-15 expression in vivo Dr. Leo Lefrançois (University of Connecticut) |
| 11:30 AM | Diverse physiological functions of IL-15Ra Dr. Averil Ma, University of California, San Francisco |
| 12:10 PM |
Lunch
|
| 1:00 PM |
Comparisons between IL-2, IL-7 and IL-15 Dr. Cliff Lane (NIAID) |
| 1:40 PM |
Levels of IL-7, IL-15 and their association with GVHD and population changes in T, NK and B cells post transplant Dr. Fran Hakim (NCI- Bethesda) |
| 2:20 PM | Coffee Break |
| 2:30 PM |
Effect of IL-15 on human and non-human primate immune responses Dr. Masaki Terabe (NCI-Bethesda) |
| 3:00 PM |
Round Up Discussion 1. Summarize what we think we know and what we do not know about IL-15 function and regulation in the body; 20 min: Waldmann, Lefrancois, Ma, Pavlakis 2. Potential clinical applications of IL-15 and paths to clinical development; 40 min: Waldmann, Rosenberg, Lane, Hakim, Terabe Roundtable chaired by Dr. John Gilly (NCI-Frederick) |
| 4:00 PM | Adjourn |
